Degayo, Jairah Dawn D.
HRN: 27-22-91 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/22/2025
CEFUROXIME 1.5GM (VIAL)
09/22/2025
09/29/2025
IV
300mg
Q8H
Acute Respiratory Infection
Checking Initial Appropriateness
11/14/2025
CEFUROXIME 750MG (VIAL)
11/14/2025
11/21/2025
IV
320mg
Q8
Pcap C With Hrad
Checking Final Appropriateness